Silicon Valley Journals

Neural Propulsion Systems, a pioneer in hyper-resolution digital imaging radar technology, today announced a new Series B strategic investment from RTX Ventures, Raytheon Technologies’ venture capital arm. The funding will assist NPS in developing next-generation radar technology capable of providing ten times the resolution and 2.5 times the range for mobility and defense applications. According … Read more

TeraPore Technologies, a developer of advanced nanofiltration membrane systems for biomanufacturing, announced today that it has raised $10 million in new capital. The round was led by existing investor Anzu Partners, with participation from Entegris, a global leader in advanced materials science, and RA Capital Management, another existing investor. TeraPore will use the funds to … Read more

JACS Capital, the family office of former GE CEO and investor Jeff Immelt, led the $3 million Series A funding round for Poppy Handcrafted Popcorn. The company also announced the appointment of Jeff Immelt to its Advisory Board and the addition of Chris Renno to its Board of Directors. The all-natural gourmet popcorn company has … Read more

Velocity Access, a Payson, Utah-based company, has raised $5 million in seed funding to continue developing its next-generation ticketing, destination management, and customer experience software suite. The suite of solutions provided by Velocity Access includes Sticky Tickets, which enables venues to have control over the fan experience with safe, secure, and verifiable ticketing technology. The … Read more

Deeptune, a New York-based software development company, has announced that it has raised $3.1 million in a seed funding round. Deeptune’s AI-powered platform helps creators expand their reach globally. The funding round was led by Seven Seven Six, a venture capital firm that primarily invests in seed rounds, and included investments from Pentas Ventures, Alexis … Read more

Chroma Medicine, a genomic medicine company that focuses on developing single-dose epigenetic editing therapeutics, announced that it has raised $135 million in Series B funding led by GV (Google Ventures). The funding round also saw participation from other new investors including ARCH Venture Partners, DCVC Bio, Mubadala Capital, and Sixth Street, and all existing investors … Read more

Thymmune Therapeutics, a biotechnology company based in Cambridge, MA, has secured $7 million in seed financing to develop its scalable thymic cell therapies. The company aims to use its technology to restore immune function in aging and disease. The funding round was led by Pillar VC, with participation from NYBC Ventures and other investors, including … Read more